Compile Data Set for Download or QSAR
maximum 50k data
Found 140 Enz. Inhib. hit(s) with all data for entry = 7410
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193603(US9199947, 101)
Affinity DataIC50:  136nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193604(US9199947, 102)
Affinity DataIC50:  184nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193605(US9199947, 103)
Affinity DataIC50:  197nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183842(US9150526, 95 | US9199947, 104)
Affinity DataIC50:  221nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193555(US9199947, 50)
Affinity DataIC50:  228nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193606(US9199947, 105)
Affinity DataIC50:  232nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193607(US9199947, 106)
Affinity DataIC50:  250nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193608(US9199947, 107)
Affinity DataIC50:  328nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193609(US9199947, 108)
Affinity DataIC50:  335nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193610(US9199947, 109)
Affinity DataIC50:  354nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193556(US9199947, 51)
Affinity DataIC50:  397nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193611(US9199947, 110)
Affinity DataIC50:  404nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193612(US9199947, 111)
Affinity DataIC50:  406nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193619(US9199947, 118)
Affinity DataIC50:  437nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193613(US9199947, 112)
Affinity DataIC50:  459nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193557(US9199947, 52)
Affinity DataIC50:  466nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193620(US9199947, 119)
Affinity DataIC50:  488nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193614(US9199947, 113)
Affinity DataIC50:  563nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193615(US9199947, 114)
Affinity DataIC50:  567nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193524(US9199947, 17)
Affinity DataIC50:  588nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193558(US9199947, 53)
Affinity DataIC50:  631nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193522(US9199947, 15)
Affinity DataIC50:  634nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193621(US9199947, 120)
Affinity DataIC50:  649nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193622(US9199947, 121)
Affinity DataIC50:  707nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193525(US9199947, 18)
Affinity DataIC50:  769nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193623(US9199947, 122)
Affinity DataIC50:  780nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193510(US9199947, 3)
Affinity DataIC50:  784nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193511(US9199947, 4)
Affinity DataIC50:  797nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193624(US9199947, 123)
Affinity DataIC50:  903nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193645(US9199947, 167)
Affinity DataIC50:  935nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193566(US9199947, 61)
Affinity DataIC50:  954nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193512(US9199947, 5)
Affinity DataIC50:  967nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193567(US9199947, 62)
Affinity DataIC50:  970nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193568(US9199947, 63)
Affinity DataIC50:  975nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193625(US9199947, 124)
Affinity DataIC50:  975nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193526(US9199947, 19)
Affinity DataIC50:  987nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193559(US9199947, 54)
Affinity DataIC50:  989nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193616(US9199947, 115)
Affinity DataIC50:  1.06E+3nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193527(US9199947, 20)
Affinity DataIC50:  1.11E+3nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193626(US9199947, 125)
Affinity DataIC50:  1.16E+3nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193528(US9199947, 21)
Affinity DataIC50:  1.18E+3nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193569(US9199947, 64)
Affinity DataIC50:  1.20E+3nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193627(US9199947, 126)
Affinity DataIC50:  1.22E+3nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193570(US9199947, 65)
Affinity DataIC50:  1.23E+3nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193628(US9199947, 127)
Affinity DataIC50:  1.23E+3nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193571(US9199947, 66)
Affinity DataIC50:  1.25E+3nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193572(US9199947, 67)
Affinity DataIC50:  1.31E+3nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193529(US9199947, 22)
Affinity DataIC50:  1.32E+3nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193629(US9199947, 128)
Affinity DataIC50:  1.33E+3nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM193530(US9199947, 23)
Affinity DataIC50:  1.39E+3nMpH: 5.5 T: 2°CAssay Description:The activated cathepsin A was diluted in assay buffer (25 mM MES, pH 5.5, containing 5 mM DTT) and mixed with the test compound (dissolved in assay b...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 140 total ) | Next | Last >>
Jump to: